Lantheus Holdings, Inc. Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount
Lantheus Holdings, Inc. (LNTH) reported Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings · last filed 2017-02-23
- Lantheus Holdings, Inc. effective income tax rate reconciliation, repatriation of foreign earnings, amount for fiscal 2016 was $0.00.
- Lantheus Holdings, Inc. effective income tax rate reconciliation, repatriation of foreign earnings, amount for fiscal 2015 was $0.00.
- Lantheus Holdings, Inc. effective income tax rate reconciliation, repatriation of foreign earnings, amount for fiscal 2014 was -$500.00K.
- Lantheus Holdings, Inc. effective income tax rate reconciliation, repatriation of foreign earnings, amount for fiscal 2013 was -$18.00K.
| Period end | Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount 12 month |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-23 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-23 |
| 2014-12-31 | -$500.00K 10-K · filed 2017-02-23 |
| 2013-12-31 | -$18.00K 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |